際際滷

際際滷Share a Scribd company logo
AETCOM
COMPETENCIES
PH 3.6: DEMONSTRATE HOW TO OPTIMIZE INTERACTION WITH
PHARMACEUTICAL REPRESENTATIVE TO GET AUTHENTIC INFORMATION
ON DRUGS.
PH 3.8: COMMUNICATE EFFECTIVELY WITH A PATIENT ON THE PROPER
USE OF PRESCRIBED MEDICATION.
PH 5.1: COMMUNICATE WITH THE PATIENT WITH EMPATHY AND
ETHICS ON ALL ASPECTS OF DRUG USE.
 PH 5.2: COMMUNICATE WITH THE PATIENT REGARDING THE
OPTIMAL USE OF:
 A. DRUG THERAPY
 B. MEDICAL DEVICE
 C. STORAGE OF MEDICINE
 PH.5.3: MOTIVATE PATIENTS WITH CHRONIC DISEASES TO ADHERE TO
THE PRESCRIBED MANAGEMENT BY THE HEALTH CARE PROVIDER
 PH.5.6: DEMONSTRATE ABILITY TO EDUCATE PUBLIC AND PATIENTS
ABOUT VARIOUS ASPECTS OF DRUG USE INCLUDING DRUG
DEPENDENCE AND OTC DRUGS.
COMPONENTS OF COMMUNICATION
 LISTENING- ATTENTIVE, CARING
 SPEAKING: RESPECTFULLY, SIMPLE/COMMON LANGUAGE
 READING: SLOW AND MEANINGFULLY
 WRITING: LEGIBLE, CLEAR
MAJOR OBJECTIVES OF COMMUNICATION
 OPEN THE DISCUSSION
 GATHER INFORMATION
 CHECK/ CLARIFY INFORMATION
 UNDERSTAND THE PATIENTS PERSPECTIVE
 SHARE INFORMATION
 ADAPT TO THE PATIENTS LEVEL OF UNDERSTANDING AND BUILD A
RELATIONSHIP
 REACH AGREEMENT ON PROBLEMS AND PLANS
 PROVIDE CLOSURE
OPEN THE DISCUSSION
 GREET APPROPRIATELY
 OUTLINE REASON
 AGENDA
 MAINTAIN PRIVACY
GATHER INFORMATION
 ELICIT PATIENTS VIEW
 EFFECT ON LIFE
 EXPLORE- PHYSICAL, PSCHOLOGICAL, EMOTIONAL
 DISCUSS-LIFESTYLE, PREVENTION STRATEGIES
 AVOID DIRECT QUESTIONS
 PROVIDE AMPLE OPPURTUNITY TO TALK
CHECK/ CLARIFY INFO
 INVISIBLE RELATIVE..GOOGLE
UNDERSTAND THE PATIENTS PERSPECTIVE
 ACKNOWLEDGE PATIENTS PROGRESS
 CHALLENGES
 WAITING TIME
 FAMILY
 CULTURAL ISSUES
 SES
 EXPRESS CARING EMPATHETIC ATTITUDE
 MAINTAIN RESPECTFUL TONE
SHARE INFORMATION
 RATIONALE OF DRUG USE
 TREATMENT ADHERENCE
ADAPT TO THE PATIENTS LEVEL OF
UNDERSTANDING AND BUILD A RELATIONSHIP
REACH AGREEMENT ON PROBLEMS AND PLANS
 INVOLVE PATIENT IN DECISION MAKING
 ASSESS PTS WILLINGNESS
 INTENTION TO FOLLOW ADVICE ON DRUGS
 ENGAGE IN PROBLEM SOLVING ASPECTS ON DIFFERENCES IN
PERSPECTIVE, UNDERSTANDING OF DRUG USE.
PROVIDE CLOSURE
 ASK IF ANYTHING ELSE TO DISCUSS
 THE PROPER USE OF ABOVE TECHNIQUES WILL HELP PHYSICIAN TO
MOTIVATE PTS TO UNDERSTAND AND IMPROVE TREATMENT
ADHERENCE.
 MOTIVATION STRATEGIES INCLUDE APPRECIATING THE EFFORTS OF
PATIENTS, GIVING MORE INFORMATION, ADD MORE RESPECT TO
PATIENT.
IMPACT OF EFFECTIVE COMMUNICATIO
 INCREASED SATISFACTION
 GREATER SYMPTOM RESOLUTION
 LOWER REFERRAL ARTES
 EFFICACY OF TREATMENT
IMPLICATIONS
 LEGAL
 LAWSUITS
PH 3.6: DEMONSTRATE HOW TO OPTIMIZE INTERACTION WITH
PHARMACEUTICAL REPRESENTATIVE TO GET AUTHENTIC INFORMATION
ON DRUGS.
PH 3.8: COMMUNICATE EFFECTIVELY WITH A PATIENT ON THE PROPER
USE OF PRESCRIBED MEDICATION.
PH 5.1: COMMUNICATE WITH THE PATIENT WITH EMPATHY AND
ETHICS ON ALL ASPECTS OF DRUG USE.
 PH 5.2: COMMUNICATE WITH THE PATIENT REGARDING THE
OPTIMAL USE OF:
 A. DRUG THERAPY
 B. MEDICAL DEVICE
 C. STORAGE OF MEDICINE
 PH.5.3: MOTIVATE PATIENTS WITH CHRONIC DISEASES TO ADHERE TO
THE PRESCRIBED MANAGEMENT BY THE HEALTH CARE PROVIDER
 PH.5.6: DEMONSTRATE ABILITY TO EDUCATE PUBLIC AND PATIENTS
ABOUT VARIOUS ASPECTS OF DRUG USE INCLUDING DRUG
DEPENDENCE AND OTC DRUGS.

More Related Content

Similar to AETCOM.pptx UTILITY AND USE IN MEDICAL EDUCATION (20)

medication adherence.pdf
medication adherence.pdfmedication adherence.pdf
medication adherence.pdf
Arbeena Shakir
L1 pharmacotherapy introduction ...pdf
L1 pharmacotherapy introduction ...pdfL1 pharmacotherapy introduction ...pdf
L1 pharmacotherapy introduction ...pdf
swr88kv5p2
PV UTILISATION, APPLICATION WHO PROGRAMME.pptx
PV UTILISATION, APPLICATION WHO PROGRAMME.pptxPV UTILISATION, APPLICATION WHO PROGRAMME.pptx
PV UTILISATION, APPLICATION WHO PROGRAMME.pptx
SAMYUKTHAKANDULA
Pharmaceutical Care
Pharmaceutical CarePharmaceutical Care
Pharmaceutical Care
rifae
final duplication and misuse ppt
final duplication and misuse pptfinal duplication and misuse ppt
final duplication and misuse ppt
shahin ghori
introduction to patient medication history ppt.pptx
introduction to patient medication history ppt.pptxintroduction to patient medication history ppt.pptx
introduction to patient medication history ppt.pptx
msachin929
MEDICATION ADHERENCE.pptx
MEDICATION ADHERENCE.pptxMEDICATION ADHERENCE.pptx
MEDICATION ADHERENCE.pptx
AnilDhakal14
Concepts of em
Concepts of emConcepts of em
Concepts of em
Mmedsc Hahm
Clinical Pharmacy (CP)
Clinical Pharmacy (CP)Clinical Pharmacy (CP)
Clinical Pharmacy (CP)
SKarthigaSVCP
Rational Drug USe - Pharmacotherapeutics -1
Rational Drug USe - Pharmacotherapeutics -1Rational Drug USe - Pharmacotherapeutics -1
Rational Drug USe - Pharmacotherapeutics -1
Ravinandan A P
Patient medication counselling.
Patient medication counselling.Patient medication counselling.
Patient medication counselling.
varshawadnere
Physician Dispensing Services
Physician Dispensing ServicesPhysician Dispensing Services
Physician Dispensing Services
dispensingphysician
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
sunayanamali
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
Brahmani baachu
Clinical Pharmacy.pptx
Clinical Pharmacy.pptxClinical Pharmacy.pptx
Clinical Pharmacy.pptx
KalloliChatterjee
Rational drug use
Rational drug useRational drug use
Rational drug use
Chanukya Vanam . Dr
Clinical errors by nursing / paramedic staff
Clinical errors by nursing / paramedic staffClinical errors by nursing / paramedic staff
Clinical errors by nursing / paramedic staff
Mohit Changani
research 3
research 3research 3
research 3
Getasew Amogne
Patient counselling
Patient counsellingPatient counselling
Patient counselling
krishna mathiyarasan
Pharmaceutical Care -Definition and Principles (1).ppt
Pharmaceutical  Care -Definition and Principles (1).pptPharmaceutical  Care -Definition and Principles (1).ppt
Pharmaceutical Care -Definition and Principles (1).ppt
AyeshaShifa2
medication adherence.pdf
medication adherence.pdfmedication adherence.pdf
medication adherence.pdf
Arbeena Shakir
L1 pharmacotherapy introduction ...pdf
L1 pharmacotherapy introduction ...pdfL1 pharmacotherapy introduction ...pdf
L1 pharmacotherapy introduction ...pdf
swr88kv5p2
PV UTILISATION, APPLICATION WHO PROGRAMME.pptx
PV UTILISATION, APPLICATION WHO PROGRAMME.pptxPV UTILISATION, APPLICATION WHO PROGRAMME.pptx
PV UTILISATION, APPLICATION WHO PROGRAMME.pptx
SAMYUKTHAKANDULA
Pharmaceutical Care
Pharmaceutical CarePharmaceutical Care
Pharmaceutical Care
rifae
final duplication and misuse ppt
final duplication and misuse pptfinal duplication and misuse ppt
final duplication and misuse ppt
shahin ghori
introduction to patient medication history ppt.pptx
introduction to patient medication history ppt.pptxintroduction to patient medication history ppt.pptx
introduction to patient medication history ppt.pptx
msachin929
MEDICATION ADHERENCE.pptx
MEDICATION ADHERENCE.pptxMEDICATION ADHERENCE.pptx
MEDICATION ADHERENCE.pptx
AnilDhakal14
Concepts of em
Concepts of emConcepts of em
Concepts of em
Mmedsc Hahm
Clinical Pharmacy (CP)
Clinical Pharmacy (CP)Clinical Pharmacy (CP)
Clinical Pharmacy (CP)
SKarthigaSVCP
Rational Drug USe - Pharmacotherapeutics -1
Rational Drug USe - Pharmacotherapeutics -1Rational Drug USe - Pharmacotherapeutics -1
Rational Drug USe - Pharmacotherapeutics -1
Ravinandan A P
Patient medication counselling.
Patient medication counselling.Patient medication counselling.
Patient medication counselling.
varshawadnere
Physician Dispensing Services
Physician Dispensing ServicesPhysician Dispensing Services
Physician Dispensing Services
dispensingphysician
Medication Adherence
Medication Adherence Medication Adherence
Medication Adherence
sunayanamali
Clinical errors by nursing / paramedic staff
Clinical errors by nursing / paramedic staffClinical errors by nursing / paramedic staff
Clinical errors by nursing / paramedic staff
Mohit Changani
Pharmaceutical Care -Definition and Principles (1).ppt
Pharmaceutical  Care -Definition and Principles (1).pptPharmaceutical  Care -Definition and Principles (1).ppt
Pharmaceutical Care -Definition and Principles (1).ppt
AyeshaShifa2

More from Chiru Uday (7)

anti-plateletagents-140120220538-phpapp02.pdf
anti-plateletagents-140120220538-phpapp02.pdfanti-plateletagents-140120220538-phpapp02.pdf
anti-plateletagents-140120220538-phpapp02.pdf
Chiru Uday
current regulatory requirements to conduct clinical research in India
current regulatory requirements to conduct clinical research in Indiacurrent regulatory requirements to conduct clinical research in India
current regulatory requirements to conduct clinical research in India
Chiru Uday
Routes of drug administration in general pharmacology.pptx
Routes of drug administration in general pharmacology.pptxRoutes of drug administration in general pharmacology.pptx
Routes of drug administration in general pharmacology.pptx
Chiru Uday
04 GENERAL PHARMACOLOGY (absorption).ppt
04 GENERAL PHARMACOLOGY (absorption).ppt04 GENERAL PHARMACOLOGY (absorption).ppt
04 GENERAL PHARMACOLOGY (absorption).ppt
Chiru Uday
Insulin.ppt
Insulin.pptInsulin.ppt
Insulin.ppt
Chiru Uday
TETRA.pptx
TETRA.pptxTETRA.pptx
TETRA.pptx
Chiru Uday
KINETICS OF ELIMINATION - Copy.ppt
KINETICS OF ELIMINATION - Copy.pptKINETICS OF ELIMINATION - Copy.ppt
KINETICS OF ELIMINATION - Copy.ppt
Chiru Uday
anti-plateletagents-140120220538-phpapp02.pdf
anti-plateletagents-140120220538-phpapp02.pdfanti-plateletagents-140120220538-phpapp02.pdf
anti-plateletagents-140120220538-phpapp02.pdf
Chiru Uday
current regulatory requirements to conduct clinical research in India
current regulatory requirements to conduct clinical research in Indiacurrent regulatory requirements to conduct clinical research in India
current regulatory requirements to conduct clinical research in India
Chiru Uday
Routes of drug administration in general pharmacology.pptx
Routes of drug administration in general pharmacology.pptxRoutes of drug administration in general pharmacology.pptx
Routes of drug administration in general pharmacology.pptx
Chiru Uday
04 GENERAL PHARMACOLOGY (absorption).ppt
04 GENERAL PHARMACOLOGY (absorption).ppt04 GENERAL PHARMACOLOGY (absorption).ppt
04 GENERAL PHARMACOLOGY (absorption).ppt
Chiru Uday
Insulin.ppt
Insulin.pptInsulin.ppt
Insulin.ppt
Chiru Uday
KINETICS OF ELIMINATION - Copy.ppt
KINETICS OF ELIMINATION - Copy.pptKINETICS OF ELIMINATION - Copy.ppt
KINETICS OF ELIMINATION - Copy.ppt
Chiru Uday

Recently uploaded (20)

PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptxPRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
karishmaduhijod1
Hemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomyHemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomy
26d78y5bwr
Regulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdfRegulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdf
MedicoseAcademics
Renal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBFRenal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBF
MedicoseAcademics
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
ABHAY INSTITUTION
bacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptxbacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptx
Dauda Yahaya masani
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the FutureCreatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Steve Jennings
Eye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptxEye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptx
KafrELShiekh University
3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular
Pooja Rani
Macafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Reviews 2024 - Macafem for Menopause SymptomsMacafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Supplement
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
PVI, PeerView Institute for Medical Education
Non-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for NeurosurgeonsNon-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for Neurosurgeons
Dhaval Shukla
3 - 8 Priority Health aaaaaaOutcomes.pdf
3 - 8 Priority Health aaaaaaOutcomes.pdf3 - 8 Priority Health aaaaaaOutcomes.pdf
3 - 8 Priority Health aaaaaaOutcomes.pdf
NashiedaLilangBuale
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
zilkerapurbo
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
maheenmazhar021
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsOptimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
KHUSHAL CHAVAN
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptxRabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Wahid Husein
MLS 208 - UNIT 4 A - Tissue Processing - ETANDO AYUK - SANU 1 - Secured.pdf
MLS 208 -  UNIT  4 A  -  Tissue Processing  - ETANDO AYUK - SANU 1 - Secured.pdfMLS 208 -  UNIT  4 A  -  Tissue Processing  - ETANDO AYUK - SANU 1 - Secured.pdf
MLS 208 - UNIT 4 A - Tissue Processing - ETANDO AYUK - SANU 1 - Secured.pdf
Eswatini Medical Christian University - EMCU / Southern Nazarene University - SANU
MLS 208 - UNIT 1- Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
MLS 208 -  UNIT 1-  Lecture Notes - ETANDO AYUK - SANU - Secured.pdfMLS 208 -  UNIT 1-  Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
MLS 208 - UNIT 1- Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
Eswatini Medical Christian University - EMCU / Southern Nazarene University - SANU
Cardiac Arrhythmias for paramedical students.
Cardiac Arrhythmias for paramedical students.Cardiac Arrhythmias for paramedical students.
Cardiac Arrhythmias for paramedical students.
helanmariaarockkiasa
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptxPRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
karishmaduhijod1
Hemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomyHemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomy
26d78y5bwr
Regulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdfRegulation of tubular reabsorption _AntiCopy.pdf
Regulation of tubular reabsorption _AntiCopy.pdf
MedicoseAcademics
Renal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBFRenal Physiology - Regulation of GFR and RBF
Renal Physiology - Regulation of GFR and RBF
MedicoseAcademics
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
PERSONALITY DEVELOPMENT & DEFENSE MECHANISMS.pptxPersonality and environment:...
ABHAY INSTITUTION
bacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptxbacterial-genetics-variation-new (1).pptx
bacterial-genetics-variation-new (1).pptx
Dauda Yahaya masani
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the FutureCreatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Creatines Untold Story and How 30-Year-Old Lessons Can Shape the Future
Steve Jennings
Eye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptxEye assessment in polytrauma for undergraduates.pptx
Eye assessment in polytrauma for undergraduates.pptx
KafrELShiekh University
3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular3. coronary circulation.pptx cardiovascular
3. coronary circulation.pptx cardiovascular
Pooja Rani
Macafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Reviews 2024 - Macafem for Menopause SymptomsMacafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Reviews 2024 - Macafem for Menopause Symptoms
Macafem Supplement
Non-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for NeurosurgeonsNon-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for Neurosurgeons
Dhaval Shukla
3 - 8 Priority Health aaaaaaOutcomes.pdf
3 - 8 Priority Health aaaaaaOutcomes.pdf3 - 8 Priority Health aaaaaaOutcomes.pdf
3 - 8 Priority Health aaaaaaOutcomes.pdf
NashiedaLilangBuale
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
zilkerapurbo
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
maheenmazhar021
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & ApplicationsOptimization in Pharmaceutical Formulations: Concepts, Methods & Applications
Optimization in Pharmaceutical Formulations: Concepts, Methods & Applications
KHUSHAL CHAVAN
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptxRabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Wahid Husein
Cardiac Arrhythmias for paramedical students.
Cardiac Arrhythmias for paramedical students.Cardiac Arrhythmias for paramedical students.
Cardiac Arrhythmias for paramedical students.
helanmariaarockkiasa

AETCOM.pptx UTILITY AND USE IN MEDICAL EDUCATION

  • 3. PH 3.6: DEMONSTRATE HOW TO OPTIMIZE INTERACTION WITH PHARMACEUTICAL REPRESENTATIVE TO GET AUTHENTIC INFORMATION ON DRUGS. PH 3.8: COMMUNICATE EFFECTIVELY WITH A PATIENT ON THE PROPER USE OF PRESCRIBED MEDICATION. PH 5.1: COMMUNICATE WITH THE PATIENT WITH EMPATHY AND ETHICS ON ALL ASPECTS OF DRUG USE.
  • 4. PH 5.2: COMMUNICATE WITH THE PATIENT REGARDING THE OPTIMAL USE OF: A. DRUG THERAPY B. MEDICAL DEVICE C. STORAGE OF MEDICINE
  • 5. PH.5.3: MOTIVATE PATIENTS WITH CHRONIC DISEASES TO ADHERE TO THE PRESCRIBED MANAGEMENT BY THE HEALTH CARE PROVIDER PH.5.6: DEMONSTRATE ABILITY TO EDUCATE PUBLIC AND PATIENTS ABOUT VARIOUS ASPECTS OF DRUG USE INCLUDING DRUG DEPENDENCE AND OTC DRUGS.
  • 6. COMPONENTS OF COMMUNICATION LISTENING- ATTENTIVE, CARING SPEAKING: RESPECTFULLY, SIMPLE/COMMON LANGUAGE READING: SLOW AND MEANINGFULLY WRITING: LEGIBLE, CLEAR
  • 7. MAJOR OBJECTIVES OF COMMUNICATION OPEN THE DISCUSSION GATHER INFORMATION CHECK/ CLARIFY INFORMATION UNDERSTAND THE PATIENTS PERSPECTIVE SHARE INFORMATION ADAPT TO THE PATIENTS LEVEL OF UNDERSTANDING AND BUILD A RELATIONSHIP REACH AGREEMENT ON PROBLEMS AND PLANS PROVIDE CLOSURE
  • 8. OPEN THE DISCUSSION GREET APPROPRIATELY OUTLINE REASON AGENDA MAINTAIN PRIVACY
  • 9. GATHER INFORMATION ELICIT PATIENTS VIEW EFFECT ON LIFE EXPLORE- PHYSICAL, PSCHOLOGICAL, EMOTIONAL DISCUSS-LIFESTYLE, PREVENTION STRATEGIES AVOID DIRECT QUESTIONS PROVIDE AMPLE OPPURTUNITY TO TALK
  • 10. CHECK/ CLARIFY INFO INVISIBLE RELATIVE..GOOGLE
  • 11. UNDERSTAND THE PATIENTS PERSPECTIVE ACKNOWLEDGE PATIENTS PROGRESS CHALLENGES WAITING TIME FAMILY CULTURAL ISSUES SES EXPRESS CARING EMPATHETIC ATTITUDE MAINTAIN RESPECTFUL TONE
  • 12. SHARE INFORMATION RATIONALE OF DRUG USE TREATMENT ADHERENCE
  • 13. ADAPT TO THE PATIENTS LEVEL OF UNDERSTANDING AND BUILD A RELATIONSHIP
  • 14. REACH AGREEMENT ON PROBLEMS AND PLANS INVOLVE PATIENT IN DECISION MAKING ASSESS PTS WILLINGNESS INTENTION TO FOLLOW ADVICE ON DRUGS ENGAGE IN PROBLEM SOLVING ASPECTS ON DIFFERENCES IN PERSPECTIVE, UNDERSTANDING OF DRUG USE.
  • 15. PROVIDE CLOSURE ASK IF ANYTHING ELSE TO DISCUSS
  • 16. THE PROPER USE OF ABOVE TECHNIQUES WILL HELP PHYSICIAN TO MOTIVATE PTS TO UNDERSTAND AND IMPROVE TREATMENT ADHERENCE. MOTIVATION STRATEGIES INCLUDE APPRECIATING THE EFFORTS OF PATIENTS, GIVING MORE INFORMATION, ADD MORE RESPECT TO PATIENT.
  • 17. IMPACT OF EFFECTIVE COMMUNICATIO INCREASED SATISFACTION GREATER SYMPTOM RESOLUTION LOWER REFERRAL ARTES EFFICACY OF TREATMENT
  • 19. PH 3.6: DEMONSTRATE HOW TO OPTIMIZE INTERACTION WITH PHARMACEUTICAL REPRESENTATIVE TO GET AUTHENTIC INFORMATION ON DRUGS. PH 3.8: COMMUNICATE EFFECTIVELY WITH A PATIENT ON THE PROPER USE OF PRESCRIBED MEDICATION. PH 5.1: COMMUNICATE WITH THE PATIENT WITH EMPATHY AND ETHICS ON ALL ASPECTS OF DRUG USE.
  • 20. PH 5.2: COMMUNICATE WITH THE PATIENT REGARDING THE OPTIMAL USE OF: A. DRUG THERAPY B. MEDICAL DEVICE C. STORAGE OF MEDICINE
  • 21. PH.5.3: MOTIVATE PATIENTS WITH CHRONIC DISEASES TO ADHERE TO THE PRESCRIBED MANAGEMENT BY THE HEALTH CARE PROVIDER PH.5.6: DEMONSTRATE ABILITY TO EDUCATE PUBLIC AND PATIENTS ABOUT VARIOUS ASPECTS OF DRUG USE INCLUDING DRUG DEPENDENCE AND OTC DRUGS.